A Salmonella longiformis bacteriophage and its application
By providing the long-tailed Salmonella phage YZA15, the problem of controlling drug-resistant Salmonella has been solved, achieving efficient sterilization of Salmonella and environmental disinfection, which is suitable for safe control in livestock and poultry breeding and processing.
Patent Information
- Application Number
- CN202510208800.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2025-02-25
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2045-02-25
AI Technical Summary
The presence of drug-resistant Salmonella makes infection control and treatment more difficult, increasing treatment costs and mortality. Existing control measures, such as antibiotic use, lead to increased drug resistance, necessitating the development of new control methods.
A Salmonella longiforme phage strain YZA15 was provided, which has good acid and alkali tolerance, heat stability and high lysis activity, and is specific to major serotypes of Salmonella. It can be used as a cleaning agent or disinfectant in livestock and poultry breeding, slaughtering and processing.
It achieves highly effective bactericidal effect against Salmonella, with a short incubation period, relatively specific host range, and is safe and free of toxic and drug-resistant genes. It is a biological antibacterial product suitable for livestock and poultry environments and products.
Smart Images

Figure CN120025989B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to a Salmonella longiformis bacteriophage and its application, belonging to the field of microbial technology. Background Technology
[0002] Salmonella ( Salmonella Salmonella (Salmonella) is a Gram-negative bacillus widely distributed in the natural environment, especially in livestock and poultry. It can cause a variety of diseases in humans and animals, including gastroenteritis, typhoid fever, and septicemia. In recent years, the problem of drug resistance in Salmonella has become increasingly serious, posing a significant challenge to public health. Studies have shown that *Salmonella typhimurium*, *Salmonella enteritidis*, and *Salmonella delbrueckii* are the most common serotypes in my country, and the diversity of drug-resistant strains is constantly increasing. This drug resistance not only reduces the effectiveness of traditional antibiotics but may also lead to more serious outbreaks.
[0003] Salmonella infection is primarily transmitted through the food chain, especially through contaminated livestock and poultry products. The presence of drug-resistant Salmonella makes infection control and treatment more difficult, increasing treatment costs and mortality. Therefore, developing novel control measures to address the threat of drug-resistant Salmonella has become a key research focus.
[0004] In livestock and poultry farming, slaughtering, and processing, Salmonella control primarily relies on good hygiene practices, vaccination, and antibiotic use. However, antibiotic overuse has led to an increase in drug-resistant strains. Therefore, non-antibiotic control methods, such as the application of bacteriophages, are gaining increasing attention. Bacteriophages, as specific bacterial viruses, can efficiently lyse target bacteria without negatively impacting the health of host animals or humans. Summary of the Invention
[0005] Purpose of the invention: The purpose of this invention is to provide a Salmonella long-tailed bacteriophage and its applications.
[0006] Technical solution: The present invention provides a Salmonella long-tailed phage, wherein the phage is Salmonella phage YZA15, which is deposited at the China Center for Type Culture Collection, with accession number CCTCC NO: M 20242878, and the deposit address is Wuhan.
[0007] Furthermore, the bacteriophage YZA15 is a long-tailed bacteriophage with a total length of 130±5 nm, of which the tail is 95±2 nm long.
[0008] Furthermore, the phage YZA15 exhibits good acid and alkali tolerance, with an optimal pH value of 3-12.
[0009] Furthermore, the bacteriophage YZA15 exhibits good thermal stability, with an optimal temperature of 40~70℃.
[0010] Furthermore, when the multiplicity of infection of the bacteriophage YZA15 with the host bacterium is 0.0001, the titer is 1.57 × 10⁻⁶. 10 PFU / mL.
[0011] The present invention also provides the use of the above-mentioned Salmonella phage in any of the following: (1) Salmonella fungicide; (2) Medications for the prevention / treatment of diseases caused by Salmonella.
[0012] Furthermore, the Salmonella species mainly include Salmonella Typhimurium, Salmonella Enteritidis, Salmonella Pullorum, and Salmonella Sanfutonburg.
[0013] The present invention also provides a cleaning agent or disinfectant for aquaculture and slaughtering environments with the above-mentioned Salmonella bacteriophage as an active ingredient.
[0014] Furthermore, the concentration of the Salmonella phage is not less than 10. 9 PFU / mL.
[0015] Beneficial effects: Compared with the prior art, the present invention has the following outstanding advantages: The present invention discloses for the first time a Salmonella phage YZA15 strain, which has good stability, no toxic resistance genes, lytic activity against the main prevalent serotypes of Salmonella (typhoid, enteritis, and pullorum disease), relatively specific host range, short incubation period, and high progeny phage burst yield. It can be applied in livestock and poultry breeding, slaughtering, processing and farming, providing a safe and efficient biological antibacterial product for the livestock and poultry environment and its products. Attached Figure Description
[0016] Figure 1 Image of phage plaques on a double-layer plate for phage YZA15; Figure 2 This is a transmission electron microscope (TEM) schematic diagram of bacteriophage YZA15. Figure 3 A complete genome sequence diagram of bacteriophage YZA15; Figure 4 A schematic diagram of the acid-base tolerance of bacteriophage YZA15; Figure 5 A schematic diagram illustrating the thermal stability of bacteriophage YZA15; Figure 6 A schematic diagram illustrating the optimal multiplicity of infection for bacteriophage YZA15; Figure 7 This is a schematic diagram of the one-step growth curve of bacteriophage YZA15. Detailed Implementation
[0017] The technical solution of the present invention will be further described below with reference to the accompanying drawings.
[0018] Example 1: Screening of bacteriophages A bacteriophage with a high titer against *Salmonella typhimurium* HDY14 (an isolate from a duck farm) isolated from animal feces (a pig farm in Yangzhou) was selected, named YZA15, and deposited at the China Center for Type Culture Collection (CCTCC) with accession number CCTCC NO: M 20242878, on December 23, 2024. The deposit name is [not specified]. Salmonella sp. phang YZA15, deposited in Wuhan. Its double-layer plate results are as follows: Figure 1 As shown.
[0019] Example 2: Transmission Electron Microscopy Observation The phage stock solution was dropped onto a 200-mesh carbon-coated copper grid. After waiting for 15 minutes, the liquid was blotted dry. The grid was stained with 2% phosphotungstic acid solution for 1 minute, blotted dry, and then the copper grid was inverted and dried under a drying lamp for 30 minutes. The grid was then magnified to 800,000 times and observed using a transmission electron microscope. Phage images were selected and saved. Figure 2 Bacteriophage YZA15 is a long-tailed phage with an icosahedral tail of 95±2 nm and a total length of approximately 130±5 nm.
[0020] Example 3: Phage Genome Assembly and Annotation Following the manufacturer's instructions, phage genomic DNA was extracted using the Qiagen MinElute Virus Spin Kit. Library construction was performed according to the instructions, using the Illumina (Vazyme Biotech Co., Ltd.) VAHTS® Universal Plus DNA Library Kit. Whole-genome sequencing was then performed using an Illumina NextSeq sequencer. To ensure the reliability of subsequent information analysis results, we used FASTP to filter and quality control the obtained raw sequencing data, cutting the adapter and removing low-quality reads and reads with a high N content, obtaining clean reads. The clean reads were then assembled using de novo using metaSPAdes software. Different k-mer lengths were tested to obtain the optimal assembly results. The clean reads were then aligned to the assembled genome sequence for statistical coverage using bwa software. Prokka was used to annotate the genome for coding genes and tRNAs. Finally, blastp was used to align the protein sequences with the NR library to obtain sequence information with high similarity for each gene in the NR library.
[0021] Table 1 Sequencing Data Quality Control Table
[0022] Table 2. Statistics on genome assembly quality
[0023] The results are shown in Tables 1 and 2. YZA15 bacteriophage is a dsDNA bacteriophage. No drug resistance or virulence genes were found during whole-genome sequencing. The genome was circular. The raw sequencing data was reduced by 19434 after filtering and quality control; the sequencing data volume was reduced by 0.03 G. No unknown bases were found, and the GC base ratio was also reduced by 0.13%.
[0024] Example 4 Functional annotation of bacteriophage genome Genes were functionally annotated using eggNOG-mapper, which includes annotation information from the COG, GO, KEGG, CAZy, BiGG, and PFAM databases.
[0025] A total of 73 (42) CDSs were predicted from the YZA15 phage genome, of which 45 CDSs encode known functions and the other 28 encode hypothetical proteins, such as... Figure 3 Table 3.
[0026] Table 3 YZA15 protein annotation information
[0027]
[0028] Example 5: Lysis spectrum of bacteriophage YZA15 The lysis of different serotypes of Salmonella by bacteriophages was determined using the double-layer plate drop method. First, the fresh bacterial suspensions shown in Table 4 were mixed with semi-solid LB medium and poured onto solid LB agar plates. After solidification, 5 μL of bacteriophage was dropped onto each plate and incubated at 37℃ for 4 h. The presence of empty plaques was observed in the spotted areas. Based on the clarity of the plaques, the results were divided into three categories: clear and bright plaques (++), relatively bright plaques (+), and no empty plaques (-).
[0029] Table 4. Determination of phage lysis profiles
[0030]
[0031]
[0032] Example 6: Acid-base tolerance of bacteriophages Adjust the pH of the SM buffer solution to 2-13 using HCl and NaOH solutions. Take 900 μL and 100 μL of SM buffer solution at each pH value and mix them in sterile EP tubes. Incubate at 37°C in a metal bath for 1 h or 2 h. Take 100 μL of each solution for serial dilution and determine the potency using the bilayer plate method.
[0033] Depend on Figure 4 It can be seen that the potency of YZA15 is relatively stable when the pH is 3-12.
[0034] Example 7: Thermal stability of bacteriophages Phage YZA15 was aliquoted into 20 portions (500 μL each) and placed in metal baths at 40℃, 50℃, 60℃, 70℃ and 80℃ for 15 min, 30 min, 45 min and 60 min respectively. Each portion was serially diluted to 100 μL, and the titer of the phage at each temperature was determined using the double-layer agar plate method.
[0035] Depend on Figure 5 It can be seen that YZA15 has good stability in the range of 40~70℃. At 80℃, the potency gradually decreases with time, and decreases by about 6 log values after 60 min.
[0036] Example 8: Determination of Optimal Multiplicity of Infection Adjust the Salmonella Typhimurium HKY14 bacterial suspension to 10. 8 CFU / mL; 100 μL of phage YZA15 at different titers was mixed with an equal volume of bacterial suspension to make a 10-1 1 10 0 10 -1 10 -2 10 -3 10 -4 The phage was diluted with LB broth to a total volume of 5 mL and incubated at 180 r / min for 4 h in a 37°C shaker. After centrifugation at 10000 rpm for 15 min, the supernatant was filtered through a 0.22 μm filter to remove bacterial precipitate. The phage titer was determined using the bilayer plate method after serial dilution with SM.
[0037] Depend on Figure 6 It can be seen that when the multiplicity of infection between the bacteriophage and the host bacteria is 0.0001, the titer of YZA15 is the highest, at 1.57 × 10⁻⁶. 10 PFU / mL.
[0038] Example 9: Determination of one-step growth curve Adjust the Salmonella Typhimurium HDY14 bacterial suspension (host bacteria) to 10. 8CFU / mL, phage YZA15 and host bacteria were mixed at MOI=0.01 and incubated at 37℃ with shaking at 180 r / min for 15 min. Then, the mixture was centrifuged at 4℃ and 4000 rpm for 15 min, the supernatant was discarded, and the precipitate was washed twice with LB liquid medium to remove free phage. Finally, the precipitate was resuspended in LB liquid medium preheated to 37℃ and incubated on a metal bath at 37℃. A serial dilution was taken every 5 min for the first 20 min, and then every 10 min for the next 20 min (for a total of 150 min) to determine the phage titer.
[0039] Depend on Figure 7 It can be seen that the latency period of YZA15 is about 5 min, the burst period is about 115 min, and the lysis rate is 33.83 PFU / cell.
[0040] Example 10 Water pollution Salmonella Typhimurium HDY14 was cultured in a shaker at 37°C and 180 r / min. The bacterial concentration was adjusted to OD600 = 1.0 with PBS, and then diluted to 1 × 10⁻⁶. 6 CFU / mL, take 100 μL of bacterial dilution and mix with an equal volume of bacteriophage YZA15 (5×10⁻⁶ CFU / mL). 9 Mix PFU / mL, add PBS to make up to 5 mL, and use SM buffer to mix with bacterial dilution as a control; take samples every 1 h, serially dilute and drop 10 μL into each petri dish, air dry and invert in a 37℃ incubator, and count colonies the next day.
[0041] The results are shown in Table 5. Bacteriophage YZA15 had a significant bactericidal effect within 5 h, and no colonies were detected.
[0042] Table 5. Bactericidal efficiency (%) of YZA15 against strain HDY14
[0043] Example 11 Application of solid surface contamination First, sterilize the spray bottle: In a clean bench, first soak and wipe it with 75% ethanol, then air dry and irradiate with UV for 4 hours. Add a certain amount of SM buffer and spray it into the culture dish 5 times (approximately 1 mL), observing for the appearance of colonies. If no colonies appear, continue adding phage stock solution to adjust the concentration of phage YZA15 to 5 × 10⁻⁶. 9 PFU / mL, spray the culture dish 5 more times, and observe for colony appearance; after confirming sterility, serially dilute the adjusted Salmonella Typhimurium HDY14 suspension to 1×10⁻⁶. 6CFU / mL, take 100 μL of bacterial dilution and spread it on a petri dish. After drying, spray the phage 5 times and let it stand at room temperature for 0, 0.5, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, and 12 hours before putting it into a 37℃ incubator. The colony count was performed the next day, and SM buffer was used as a control.
[0044] The results, as shown in Table 6, indicate that the bactericidal efficiency of bacteriophage YZA15 spray against Salmonella Typhimurium HDY14 within 12 h is >99.5%. Table 6. Bactericidal efficiency (%) of bacteriophage YZA15 spray against HKY14 strain
[0045] Example 12 Application of Particulate Solid Pollution First, put 10 6 Spray the granular bedding with a mixture of CFU / mL Salmonella Typhimurium HKY14 bacterial suspension 40 times, followed by spraying with bacteriophage YZA15 (5×10⁻⁶). 9 The concentration of PFU / mL was measured. After 20 sprays, the time was recorded as 0h, and data before and after each spray were recorded. A second spray of the same amount of phage was performed at 36h. At 72h, each group was sprayed with bacterial solution 5 times. At 84h, phage was sprayed 10 times. Before and after each spray, bedding particles were weighed and used for colony counting. Approximately 1 mL was sprayed every 5 times, with a total of 3 replicates.
[0046] Table 7. Bactericidal efficiency (%) of bacteriophage YZA15 spray against HKY14 strain
[0047] The results are shown in Table 7. The bactericidal efficiency of Salmonella Typhimurium HDY14 within 12 h after spraying with bacteriophage is >99.5%.
Claims
1. A bacteriophage of Salmonella enterica serovar sp. Indica, characterized in that, The bacteriophage is Salmonella phage YZA15, deposited at the China Center for Type Culture Collection (CCTCC) with accession number CCTCC NO: M 20242878, deposited on December 23, 2024, and located in Wuhan, China. The bacteriophage can be used to lyse Salmonella, including Salmonella Typhimurium, Salmonella Enteritidis, Salmonella Pullorum, and Salmonella Sanfutoni.
2. The *Salmonella longiformis* bacteriophage according to claim 1, characterized in that, The bacteriophage YZA15 is a long-tailed bacteriophage with a total length of 130±5 nm, of which the tail is 95±2 nm long.
3. The Salmonella long-eared bacteriophage of claim 1, characterized in that, The bacteriophage YZA15 exhibits good acid and alkali tolerance, with an optimal pH value of 3-12.
4. The Salmonella long-eared bacteriophage of claim 1, characterized in that, The bacteriophage YZA15 exhibits good thermal stability, with an optimal temperature of 40~70℃.
5. Use of the Salmonella sp. long-tailed bacteriophage according to any one of claims 1 to 4 for the preparation of a bactericidal agent for Salmonella sp., characterized in that, The Salmonella species include Salmonella Typhimurium, Salmonella Enteritidis, Salmonella Pullorum, and Salmonella Sanfutonburg.
6. A cleaning agent or disinfectant for aquaculture and slaughtering environments that uses the Salmonella bacteriophage as an active ingredient as described in claim 1.
7. A cleaner or disinfectant for a farming and slaughter environment according to claim 6, characterised in that, The concentration of the Salmonella bacteriophage is not less than 10 9 PFU / mL.
Citation Information
Patent Citations
Salmonella bacteriophage CKT1 without transduction of drug-resistant gene and application of salmonella bacteriophage CKT1
CN114717199A
Salmonella bacteriophage SP8, bacteriophage composition and application thereof
CN116286671A
Broad-spectrum high-efficiency salmonella bacteriophage and application thereof
CN118374459A
